(MOS) The Mosaic Company Company Overview

US | Basic Materials | Agricultural Inputs | NYSE

(MOS) The Mosaic Company Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5

TOTAL:

What does The Mosaic Company do?

The Mosaic Company is a crop-nutrient producer and marketer whose core job is to turn mined phosphate rock and potash ore into fertilizer products that help farmers replenish nutrients removed from soil. In plain English, Mosaic sits upstream of farmers but downstream of geology: it mines, processes, blends, imports, distributes, and sells nutrients that influence crop yield and farm economics. The company describes its purpose as helping to feed the world responsibly and sustainably on its official business overview, but the investment story is more specific: this is a cyclical, asset-heavy materials company tied to global crop prices, fertilizer affordability, raw-material costs, mining reliability, environmental obligations, and working capital.

$12.1B
FY2025 net sales
$3.0B
Q1 2026 net sales
13,000+
employees cited by Mosaic
40+
countries served by Mosaic

Where do Mosaic's assets fit in the fertilizer chain?

Mosaic reports three main operating segments: Phosphate, Potash, and Mosaic Fertilizantes. Phosphate includes U.S. mines and chemical plants, including Florida and Louisiana operations, and a 75% economic interest in the Miski Mayo phosphate rock mine in Peru. Potash includes Canadian and U.S. potash mining assets, with Canadian export volumes marketed through Canpotex outside the United States and Canada. Mosaic Fertilizantes is the South American platform, with Brazilian phosphate mines, chemical plants, distribution assets, blending capability, and a commercial footprint in Brazil and Paraguay.

Identity item Company-specific answer Why it matters for analysis
Official name and ticker The Mosaic Company, common stock ticker MOS on the New York Stock Exchange The stock is one-share public equity exposure to a global fertilizer-cycle business, not a diversified agricultural company.
Core products Phosphate crop nutrients, potash crop nutrients, performance products, crop nutrient blends, and related distribution products The mix creates exposure to both commodity nutrients and higher-value formulated products.
FY2025 scale FY2025 net sales were $12.1B, with $24.5B of total assets at December 31, 2025 High asset intensity means depreciation, sustaining capital, environmental liabilities, and commodity-cycle timing matter.
Main regions FY2025 sales included $4.3B in the United States and $7.7B internationally, including $4.7B in Brazil Brazil is not a side market; it is a central demand, distribution, currency, and credit-risk exposure.

Who are Mosaic's customers?

Mosaic sells to agricultural retailers, wholesalers, distributors, industrial customers, and growers through regional channels rather than directly to a single consumer brand audience. That customer structure makes the company sensitive to farm income, crop prices, fertilizer affordability, retailer inventory behavior, credit availability in Brazil, and the timing of planting seasons. A strong research brief therefore should treat Mosaic as a global input supplier whose demand is linked to food production, but whose earnings power is set by nutrient prices, unit volumes, cost curves, logistics, and operating reliability.

Crop nutrientsMining and processingBrazil distributionCanpotex exportsPerformance productsMosaic Biosciences

How does Mosaic make money?

Mosaic makes money by selling nutrient products at prices that exceed the full cost of mining, purchasing raw materials, processing, shipping, selling, and maintaining environmental compliance. The important point is that revenue is not subscription-like or recurring in the software sense. It is mostly product revenue, and the spread between selling price and delivered cost can change quickly when potash, DAP, sulfur, ammonia, energy, freight, foreign exchange, or customer credit conditions move.

Which segment generates the most revenue?

In FY2025, Mosaic Fertilizantes generated the largest external sales base, Phosphate was second, and Potash was smaller by sales but stronger by margin. According to Mosaic's 2025 annual report, FY2025 external customer sales were $4.8B for Mosaic Fertilizantes, $3.9B for Phosphate, $2.7B for Potash, and $0.7B for Corporate, Eliminations and Other. That mix is crucial: revenue size and profit contribution are not the same thing.

Mosaic Fertilizantes
$4.8B

FY2025 external sales; Brazil-centered production, distribution, blending, and credit exposure.

Phosphate
$3.9B

FY2025 external sales; U.S. phosphate mining and chemical conversion with raw-material sensitivity.

Potash
$2.7B

FY2025 external sales; lower revenue than Brazil, but FY2025 segment gross margin was $870.0M.

Corporate and other
$0.7B

FY2025 external sales; includes China and India distribution and other corporate-level items.

FY2025 external customer sales mix
Fertilizantes$4.8B
Phosphate$3.9B
Potash$2.7B
Corporate and other$0.7B
Rows are ordered by FY2025 external sales; bar width is scaled to the largest segment.

How do prices, volumes, and raw materials convert into margin?

The economic engine is a margin spread. Potash profitability is driven by tonnes sold, realized MOP prices, mine costs, royalties and resource taxes, and export logistics. Phosphate profitability depends on finished-product prices such as DAP and MAP, rock mining, sulfur and ammonia inputs, conversion costs, and plant operating rates. Brazil adds a different layer: local production, imported products, distribution spreads, customer credit, and Brazilian real exposure.

Revenue stream Pricing logic Key cost or constraint Analytical implication
Potash crop nutrients Commodity-linked MOP and specialty potash product pricing Mine operating cost, resource taxes, rail and export logistics Small price changes can move EBITDA materially because fixed assets are large.
Phosphate crop nutrients DAP, MAP, MicroEssentials and related finished-product prices Sulfur, ammonia, rock quality, conversion cost, plant uptime Raw-material inflation can compress margins even when selling prices rise.
Brazil distribution and production Local fertilizer pricing, blends, produced products and imports Credit conditions, FX, local demand timing, distribution spreads Brazil can support scale but adds working-capital and customer-credit cyclicality.
Performance and biological products Premium crop-nutrition and biological products sold through agronomic channels Adoption, agronomic proof, channel reach and product development This is the mix-upside area, but it starts from a smaller revenue base.
1. Mine and source
Phosphate rock, potash ore, sulfur, ammonia and purchased nutrients set the input base.
2. Process and blend
Chemical conversion, concentration, blending and formulation create sellable nutrients.
3. Move through channels
Export logistics, regional terminals, retailers and Brazil distribution influence delivered economics.
4. Realize spread
The realized margin depends on price, volume, plant uptime, cost inflation and working capital.

What did Mosaic's latest quarter show?

The latest official reporting period shows why Mosaic cannot be analyzed from revenue growth alone. For Q1 2026, Mosaic reported higher net sales than Q1 2025, but also a GAAP operating loss and net loss because segment charges, phosphate raw-material pressure, and Brazil portfolio actions weighed on reported results. The company's Q1 2026 earnings release reported net sales of $3.0B, adjusted EBITDA of $416M, adjusted EPS of $0.05, and a GAAP net loss attributable to Mosaic of $258M for the quarter ended March 31, 2026.

What changed in Q1 2026?

$3.0B
Q1 2026 net sales, up from $2.6B in Q1 2025
$(373)M
Q1 2026 operating loss
$(258)M
Q1 2026 net loss attributable to Mosaic
$416M
Q1 2026 adjusted EBITDA
Metric Q1 2026 Q1 2025 Interpretation
Net sales $2,998.0M $2,620.9M Revenue increased, but the margin structure deteriorated.
Gross margin $235.6M $488.4M Q1 2026 gross margin was 7.9% of net sales, down from 18.6% in Q1 2025.
Operating earnings $(372.9)M $338.5M Charges and weaker segment profitability turned operating income negative.
Diluted EPS $(0.81) $0.75 GAAP earnings moved from profit to loss on a per-share basis.
Operating cash flow $104.2M $(174.4)M Cash generation improved versus Q1 2025, but capex still exceeded CFO.
Capital expenditures $356.8M $297.8M Asset intensity remained high in the latest quarter.

Why do reported losses and adjusted EBITDA tell different stories?

The gap between GAAP loss and adjusted EBITDA is not a cosmetic detail. Q1 2026 included a $232.6M loss on assets to be sold and $240.0M of other operating expense, while segment EBITDA still showed a profitable Potash business and positive adjusted EBITDA in Phosphate and Mosaic Fertilizantes. The latest Form 10-Q for the quarter ended March 31, 2026 is important because it separates segment economics, balance-sheet obligations, cash flow, and asset-sale accounting.

Q1 2026 positive segment adjusted EBITDA contribution
Potash$275M
Phosphate$115M
Fertilizantes$79M
Bars compare positive segment adjusted EBITDA in Q1 2026. Corporate and other was $(53)M, reducing consolidated adjusted EBITDA to $416M.

Which assets and products matter most through the fertilizer cycle?

The segment story is a cycle story. Mosaic Fertilizantes was the largest FY2025 external-sales segment, Potash was the highest-margin segment, and Phosphate was strategically central but more exposed to raw-material volatility in the latest quarter. For students and investors, that means the company should not be modeled as one blended fertilizer margin. Each segment has a different sensitivity to price, cost, capex, working capital, and operational reliability.

Why does potash carry the stronger margin profile?

Potash generated $870.0M of FY2025 gross margin and $637.7M of FY2025 operating earnings, even though its FY2025 external sales were lower than both Fertilizantes and Phosphate. In Q1 2026, Potash generated $275M of adjusted EBITDA, sold 2.2M tonnes, realized an MOP selling price of $265 per tonne FOB mine, and reported a cash cost of $84 per tonne. That explains why potash often receives disproportionate attention in Mosaic analysis: the segment can be a large profit contributor when volumes and prices are healthy.

46%
Potash represented about 46% of Mosaic's FY2025 gross margin, calculated from $870.0M of Potash gross margin divided by $1,901.9M of total FY2025 gross margin.

Why is phosphate more constrained by sulfur and ammonia?

Phosphate can have strong revenue visibility because crop nutrients remain essential, but its cost structure is exposed to sulfur, ammonia, conversion costs, rock quality, and plant operating rates. In Q1 2026, Mosaic reported Phosphate net sales of $1.4B, volume of 1.9M tonnes, DAP selling price of $668 per tonne, conversion cost of $124 per tonne, blended rock cost of $86 per tonne, and gross margin of only $2 per tonne. The company also said raw material costs increased by $280M in the quarter and later withdrew FY2026 phosphate production guidance because of raw-material supply constraints.

What did the Brazil platform change?

Mosaic Fertilizantes gives Mosaic scale in Brazil, one of the world's most important agricultural markets, but it also adds local credit, currency, and distribution-margin exposure. In FY2025, Brazil accounted for $4.7B of Mosaic sales, making it the largest single country exposure in the company's geographic table. In Q1 2026, Mosaic Fertilizantes reported $937M of net sales and $79M of adjusted EBITDA, but also a $422M operating loss because of $442M of charges tied to strategic actions. That combination shows the trade-off: Brazil can be a major growth and distribution platform, but it can also create volatility that is not visible in a simple consolidated revenue chart.

Annual revenue trend: FY2023 to FY2025
$13.7BFY2023
$11.1BFY2024
$12.1BFY2025
Column heights are scaled to FY2023, the highest revenue year in this three-year annual series.

What turning points still shape Mosaic today?

Mosaic's history matters because the company was built through asset combinations, international expansion, and portfolio choices rather than a single product invention. The strategic pattern is clear: build scale in core nutrients, manage commodity-cycle exposure, improve the portfolio, and use selective growth areas to reduce dependence on commodity fertilizer pricing.

Which strategic turning points still matter?

  1. 2004Mosaic was formed through the combination of IMC Global and Cargill Crop Nutrition, creating a larger phosphate and potash platform that still defines the company's core asset base.
  2. 2011Cargill divested its majority equity interest, increasing public-market relevance and making Mosaic a more conventional public-company governance case.
  3. 2018The Brazil platform from the Vale Fertilizantes transaction deepened Mosaic's exposure to South American agriculture, distribution, and local tax and credit complexity.
  4. 2024Mosaic exchanged its 25% MWSPC interest for Ma'aden shares, simplifying its phosphate joint-venture exposure but adding mark-to-market effects outside core operating segments.
  5. 2025FY2025 net sales recovered to $12.1B from $11.1B in FY2024, but free cash flow remained negative because capital expenditures of $1.36B exceeded operating cash flow of $824.8M.
  6. 2026The Carlsbad sale, Araxa and Patrocinio strategic alternatives, and Q1 2026 Brazil charges show an active portfolio review rather than passive ownership of every legacy asset.
Mosaic's strategic tension is that it needs commodity-scale assets to compete, but it also needs portfolio discipline, specialty products, and operating reliability to reduce the earnings swings those assets create.

What gives Mosaic a competitive advantage in crop nutrients?

Mosaic's competitive advantage is not a consumer brand moat. It is a combination of reserves, mining and processing capacity, logistics, export channels, agronomic product development, regional distribution, and customer relationships. In commodity nutrients, delivered cost and reliability matter. In performance products, agronomic value and channel trust matter. The company's North America business page states that Mosaic accounts for a large share of estimated annual North American phosphate and potash production, which helps explain its relevance in regional supply.

How do scale and market access protect the model?

Scale helps in three ways. First, a large asset base can support long-lived production through cycles. Second, logistics and export channels create market access that smaller producers cannot easily duplicate. Third, the company can allocate capital across Potash, Phosphate, Brazil, specialty products, and portfolio actions rather than rely on one mine or one geography. That said, scale is not immunity. When raw-material inflation, plant outages, environmental obligations, or customer credit pressure emerge, the same fixed assets can amplify downside.

High differentiation / Lower commodity exposure
Biologicals and specialty crop-nutrition products can improve mix, but they are still small relative to core nutrients.
Scale assets / Commodity-cycle exposure
Mosaic's core position: large phosphate and potash assets with earnings driven by nutrient prices, volumes, costs, and uptime.
Distribution reach / Credit sensitivity
Brazil distribution deepens customer access while adding working-capital, FX, and credit-cycle risk.
Small asset base / Price taker
This is where smaller nutrient suppliers may face weaker bargaining and logistics leverage.
Positioning frame: Mosaic's moat is strongest where scale, access to resources, and distribution reach combine, but the company remains exposed to commodity pricing.

How do performance products and Biosciences change the mix?

Mosaic's product pages emphasize performance products such as MicroEssentials, Aspire, and other advanced crop-nutrition offerings, while management has also called out Mosaic Biosciences as a growth platform. On the official products page, the company frames these offerings around nutrient efficiency and modern agronomic needs. In Q1 2026, management said Mosaic Biosciences expected to launch eight to ten new products during 2026, with 2026 revenue expected to double 2025 net sales of $68M. That is not yet large enough to transform the entire company, but it is strategically important because it can create a more differentiated revenue stream than commodity MOP or DAP.

8-10new Mosaic Biosciences products expected to launch in 2026, according to the Q1 2026 company update.

How financially strong is Mosaic through the cycle?

Mosaic has the scale and asset base of a major producer, but the latest financials show a balance between resilience and pressure. FY2025 was profitable on a GAAP basis, with $540.7M of net earnings attributable to Mosaic and diluted EPS of $1.70. However, FY2025 operating cash flow of $824.8M did not cover $1.36B of capital expenditures, and Q1 2026 free cash flow was also negative. That makes capex, working capital, asset sales, debt, and dividend coverage central to any financial-health analysis.

What do the balance sheet and cash flow say?

Financial item Latest figure Period Why it matters
Cash and cash equivalents $281.8M March 31, 2026 Cash was modest relative to total assets and debt, so liquidity depends on broader financing capacity and cash generation.
Total assets $24.6B March 31, 2026 The business is capital intensive, with $13.7B of net property, plant and equipment.
Short-term debt $1.2B March 31, 2026 Short-term funding is a monitor item during weak fertilizer cycles or working-capital builds.
Long-term debt $4.3B March 31, 2026 Debt service and refinancing capacity matter when cash flow turns negative.
Operating cash flow $104.2M Q1 2026 Positive CFO was not enough to fund Q1 2026 capital expenditures.
Free cash flow $(252.6)M Q1 2026 Calculated as Q1 2026 operating cash flow of $104.2M minus capex of $356.8M.

How does capital allocation affect the story?

Mosaic's capital allocation is constrained by the need to maintain mines, plants, environmental systems, logistics, and balance-sheet flexibility. FY2025 dividends paid were $280.4M, while no shares were repurchased in FY2025 despite board-approved repurchase capacity. Q1 2026 included a regular dividend of $0.22 per share and management guidance for about $1.25B of FY2026 capital expenditures. For a DCF, that means reinvestment is not optional; sustaining and reliability capital must be modeled before assuming excess cash is available for buybacks or faster deleveraging.

Asset scaleStrong, $24.6B Q1 2026 assets
Cash conversionPressured, negative Q1 2026 FCF
Leverage flexibilityModerate, $5.5B total short and long-term debt
Commodity resilienceCyclical, tied to nutrient prices and raw materials

Who owns Mosaic stock, and why does governance matter?

Mosaic has a dispersed public-company ownership structure rather than founder voting control. That matters because the investor base is primarily institutional, board accountability is exercised through normal proxy voting, and capital allocation is judged against commodity-cycle discipline. Mosaic's 2026 proxy statement listed 12 director nominees and disclosed several large institutional beneficial holders as of the proxy record context.

Who has disclosed beneficial ownership?

Holder or group Disclosed shares or stake Source period Why it matters
Fidelity Management & Research Company 39,980,661 shares, 12.58% Proxy disclosure based on December 31, 2025 Schedule 13G/A information A major passive or active institutional holder can influence governance through voting and stewardship expectations.
The Vanguard Group 37,463,432 shares, 11.79% Proxy disclosure based on December 29, 2023 Schedule 13G/A information Large index-oriented ownership usually emphasizes board process, risk oversight, and capital discipline.
BlackRock 21,250,408 shares, 6.69% Proxy disclosure based on March 31, 2025 information Institutional voting power matters more than insider control at Mosaic.
Directors and executive officers as a group 988,177 shares, less than 1% April 2, 2026 record context Management ownership is meaningful for alignment but does not create voting control.

How should governance be interpreted?

For Mosaic, governance analysis should focus less on control premiums and more on oversight of safety, environmental remediation, capital allocation, portfolio pruning, and executive incentives through the cycle. Bruce Bodine became the CEO figure investors associate with the current strategy, while Gregory Ebel served as board chair in the 2026 proxy materials. Because insiders do not control the vote, institutional shareholders and directors have a larger role in evaluating whether management is balancing production ambitions, capex, debt, dividends, asset sales, and environmental obligations prudently.

What risks and opportunities could change Mosaic's outlook?

Mosaic's opportunity set and risk profile are two sides of the same asset base. Strong fertilizer demand, potash price recovery, better phosphate uptime, Brazil portfolio improvement, and specialty-product growth can improve earnings. The same model can be pressured by raw-material costs, weak farm economics, foreign exchange, credit constraints, environmental spending, plant reliability, regulatory obligations, and capital intensity.

Which risks are most company-specific?

Risk area Company-specific evidence Financial line to monitor Interpretation
Commodity price cycle FY2025 MOP price was $255 per tonne and DAP price was $670 per tonne; management sensitivity shows $10 per tonne price moves can affect EBITDA. Net sales, gross margin, adjusted EBITDA Price changes can move profit faster than they move volumes.
Phosphate raw materials Q1 2026 phosphate raw-material costs increased by $280M, and FY2026 phosphate production guidance was withdrawn. Phosphate gross margin per tonne Sulfur, ammonia, and operating rates are immediate drivers of segment profitability.
Brazil credit and portfolio risk Q1 2026 included $442M of charges in Mosaic Fertilizantes and management cited credit constraints in Brazil. Brazil operating earnings, receivables, working capital Distribution scale can become a liability when customer credit tightens.
Environmental obligations The Q1 2026 10-Q disclosed environmental accruals of about $171.8M and a $55.5M reserve for New Wales West Stack repairs. ARO, environmental accruals, capex Gypstack, water, and closure obligations can require cash even when the commodity cycle is weak.
Capital intensity FY2025 capex was $1.36B, and Q1 2026 capex was $356.8M. Free cash flow and debt High sustaining capex reduces the amount of EBITDA that becomes distributable cash.

Which opportunities is management targeting?

The opportunity case is not simply higher fertilizer prices. Mosaic's strategy page points to three priorities: Excel Together, Elevate Core Business, and Pursue Value-Creating Growth. Management targets include technology and AI benefits, a more reliable core asset base, Brazil cost competitiveness, capital reallocation, intelligent distribution, Mosaic Biosciences, and new minerals opportunities. Those initiatives matter because they can improve margin durability if they reduce downtime, lower cost, monetize noncore assets, or scale more differentiated products.

Potash MOP price
Watch realized MOP price versus cash cost; Q1 2026 MOP FOB mine was $265 per tonne and cash cost was $84 per tonne.
Phosphate gross margin per tonne
Q1 2026 gross margin was $2 per tonne, so even modest cost or price changes can be important.
Brazil credit conditions
Distribution margins and receivables risk are key signals for Mosaic Fertilizantes.
Free cash flow
Q1 2026 free cash flow was about $(253)M; improvement requires CFO to exceed capex.
Capex discipline
Management guided to about $1.25B of FY2026 capital expenditures.
Portfolio actions
Carlsbad, Araxa and Patrocinio actions signal capital reallocation and potential simplification.

Why does Mosaic matter for valuation and DCF work?

Mosaic is a useful DCF case because the value is not driven by a simple revenue growth curve. The analyst has to normalize a fertilizer cycle, estimate sustainable segment margins, forecast capex and environmental cash needs, think carefully about Brazil working capital, and avoid treating adjusted EBITDA as free cash flow. A reasonable model must separate volume, price, cost, reinvestment, taxes, debt, and asset sales rather than apply one flat margin to consolidated sales.

Which assumptions matter most in a DCF?

Normalized nutrient prices
Potash and DAP price assumptions have high operating leverage because production assets carry large fixed costs.
Segment margin mix
Potash generated 45.7% of FY2025 gross margin, while Brazil generated the largest external sales base.
Sustaining capex
FY2025 capex of $1.36B and FY2026 guidance of about $1.25B show why reinvestment assumptions are central.
Environmental and closure cash flows
Gypstack, water, asset retirement and repair reserves can turn accounting obligations into cash requirements.
Brazil working capital
Customer credit and distribution margins can affect both earnings quality and cash conversion.
Portfolio simplification
Asset sales and strategic alternatives can release capital or crystallize losses depending on execution.

What should students and investors monitor next?

The cleanest monitoring list is operational rather than promotional: potash production near the roughly 9.0M-tonne FY2026 expectation, phosphate raw-material supply, DAP and MOP realized prices, Brazilian customer credit, capex versus the $1.25B FY2026 guide, free cash flow after sustaining capital, environmental accrual changes, and progress toward management's cost, distribution, and Mosaic Biosciences targets. These metrics connect directly to a model's revenue, margin, reinvestment, terminal-value, and balance-sheet assumptions.

Key takeaway

Mosaic is important because it is one of the major public-market ways to study global crop-nutrient economics across phosphate, potash, and Brazil distribution. The company has scale, resource access, customer channels, and specialty-product ambitions, but it remains a cyclical, capital-intensive materials business. The strongest version of the Mosaic thesis depends on better potash economics, restored phosphate reliability, disciplined Brazil portfolio actions, and free cash flow improvement after capex. The weakest version comes from raw-material pressure, environmental costs, credit stress in Brazil, and a cycle where EBITDA does not convert into cash. For a student, researcher, or investor, the central question is not whether fertilizer is necessary; it is whether Mosaic can turn necessary nutrients into durable cash flow through the cycle.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.